 | Up a level |
Dal Pra, A.; Ghadjar, P.; Hayoz, S.; Spratt, D.E.; Liu, V.Y.; Todorovic, T.; Davicioni, E.; Huang, H.C.; Schär, C.; Hölscher, T.; Gut, P.; Polat, B.; Hildebrandt, G.; Mueller, A.C.; Plasswilm, L.; Thalmann, G.; Zwahlen, D.R.; Aebersold, D.M. (2021). Performance of a Genomic Classifier (GC) Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy (SRT) After Radical Prostatectomy (RP). International journal of radiation oncology, biology, physics, 111(3, Suppl. 1), S49-S50. Elsevier 10.1016/j.ijrobp.2021.07.132
Zoni, E.; Bovet, C.; Spahn, M.; Thalmann, G.; Kruithof-de Julio, M. (4 September 2019). LC-MS metabolic profiling of plasma from patient with high prostate cancer risk (Unpublished). In: 75. Jahresversammlung SGU. Zürich. 04. - 06.09.2019.
Parker, C. C.; Sydes, M. R.; Mason, M. D.; Clarke, N. W.; Aebersold, D.; de Bono, J. S.; Dearnaley, D. P.; Ritchie, A. W. S.; Russell, J. M.; Thalmann, G.; Parmar, M. K. B.; James, N. D. (2013). Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial. Clinical oncology, 25(5), pp. 318-320. Elsevier 10.1016/j.clon.2013.01.005
